Vector Biomed Inc.
Lentiviral vectors for gene therapy research and manufacturing
- Sector
- Biotech
- Headquarters
- GAITHERSBURG, MD
- Founded
- 2021
- Latest Form D
- $7.5M, Dec 2022
- Total capital
- $9.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $7.5M
- 1 Form D · last Dec 2022
- 47 months since last filing
- Federal contracts
- $2.2M
- 4 awards · Health and Human S
- Rank in Biotech#133 of 4373
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Federal contractHealth and Human S · Production Of A Lentiviral Vector$653K
- Federal contractHealth and Human S · Services For The Production And Stability Testing Of Clinical Grade Lentiviral Vector, In Support Of The Hhs, NIH, National Cancer Institute (nci), Center For Cancer Research (ccr), Pediatric Oncology Branch (pob)$804K
- Federal contractHealth and Human S · Production Of A Lentiviral Vector, CX170 From Vector Biomed$612K
- Federal contractHealth and Human S · Acquisition Of Services To Obtain Preclinical Grade Lentiviral Vectors In Support Of The Hhs, NIH, National Cancer Institute (nci), Center For Cancer Research (ccr), Pediatric Oncology Branch (pob)$121K
- Private capital raisedForm D · SEC · 1st filing$7.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Boro DropulicExecutive Officer, DirectorNamed in SEC Form D filings
- James KennyDirectorNamed in SEC Form D filings
- Peter LeeDirectorNamed in SEC Form D filings
What it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- WILSON WOLF MANUFACTURING CORPORATIONSimilar federal contract value in Biotech · $2.3M in contracts
- MODULATION THERAPEUTICS, INC.Similar federal contract value in Biotech · $2.3M in contracts
- VIEWPOINT MOLECULAR TARGETING, INC.Similar federal contract value in Biotech · $2.2M in contracts
- MerusSimilar federal contract value in Biotech · $2.1M in contracts
- GENCIRQ, INC.Similar federal contract value in Biotech · $2M in contracts
- BUFFALO BIOLABS, LLCSimilar federal contract value in Biotech · $2M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .